United Kingdomi February News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Revolo Biotherapeutics Receives MHRA Approval for Two Phase 2 Clinical Trials of ‘1805 in Autoimmune Diseases in the United Kingdom

United statesUnited kingdomCity ofJonathan rigbyRevolo biotherapeuticRevolo biotherapeuticsRevolo bioRegulatory agencyTwo phaseAutoimmune diseasesUnited kingdomi februaryRheumatoid arthritisPosterior uveitisEosinophilic esophagitisChief executive officerImmune therapy